UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027285
Receipt number R000031267
Scientific Title Analyses of the skin molecules in the patient of atopic dermatitis.
Date of disclosure of the study information 2017/05/23
Last modified on 2019/06/25 12:39:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analyses of the skin molecules in the patient of atopic dermatitis.

Acronym

Analyses of the skin molecules in the patient of atopic dermatitis.

Scientific Title

Analyses of the skin molecules in the patient of atopic dermatitis.

Scientific Title:Acronym

Analyses of the skin molecules in the patient of atopic dermatitis.

Region

Japan


Condition

Condition

Atopic dermatitis

Classification by specialty

Dermatology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Evaluation of the skin molecules in the patients of atopic dermatitis.

Basic objectives2

Others

Basic objectives -Others

The observational study the relationship between skin molecules and status of atopic dermatitis.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The relationship between skin molecules and status of atopic dermatitis.

Key secondary outcomes

The relationship between skin molecules and questionnaires.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

1.Japanese male panelists who are 20-59 years old.
2.Panelists with atopic dermatitis more than mild condition.
3.Panelists who have normal weight (BMI: Between 18.5 and 25.0)
4.Panelists who agree to have their typical daily routines.

Key exclusion criteria

1.Panelists who use the steroid and immunosuppressant in face for more than 2 weeks during a month.
2.Panelists who used the antibiotics in the last 2 weeks.
3.Panelists who have the disease, such as diabetes, affecting on this study.
4.Panelists who use the drugs affecting on this study.
5.Panelists who have undergone
some beauty treatments on their faces.
6.Panelists participating in, or scheduled to participate in, another study during the study period.
7.Panelists who smoke.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshito Takahashi

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

5-3-28, Kotobuki-machi, Odawara-shi, Kanagawa, 250-0002, JAPAN

TEL

0465-34-6116

Email

takahashi.yoshito@kao.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Takayoshi Inoue

Organization

Kao Corporation

Division name

R&D -Core Technology- Biological Science Research

Zip code


Address

2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN

TEL

0285-68-7498

Homepage URL


Email

inoue.takayoshi@kao.co.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

株式会社インフォワード(東京都)


Other administrative information

Date of disclosure of the study information

2017 Year 05 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 05 Month 23 Day

Date of IRB

2017 Year 05 Month 23 Day

Anticipated trial start date

2017 Year 06 Month 01 Day

Last follow-up date

2019 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Panelists will be recruited by Inforward, inc.


Management information

Registered date

2017 Year 05 Month 09 Day

Last modified on

2019 Year 06 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031267


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name